指定血栓-受体相互作用的域
T K Vu1, V I Wheaton, D T Hung
1Cardiovascular Research Institute, University of California, San Francisco 94143-0524.
Nature
|October 17, 1991
概括
研究人员设计了一种新型的血受体,该受体由化酶激活,而不是血. 这项研究揭示了对血凝素受体激活和潜在的新药向血凝症的关键见解.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血小板通过血栓激活在动脉血栓形成中至关重要.
- 血小板血受体 (PAR1) 是一个七个跨膜域受体.
- 血分裂受体的细胞外域,以启动信号传输.
研究的目的:
- 为了研究激素受体激活的基本元素.
- 为了设计一种具有改变激活特性的修改后的血栓受体.
- 为了阐明血栓的高亲和力和强度的结构基础.
主要方法:
- 位点导向的突变发生,以取代血栓裂变部位的肠激酶裂变部位.
- 功能性测试用于测量由肠激酶和血栓激素激活受体.
- 结构分析以确定参与血栓结合的域.
主要成果:
- 成功创建了一个功能性肠酶受体,证明蛋白质分解足以激活.
- 工程接收器需要纳米分子肠激酶度,与野生类型接收器的皮科莫尔血栓不同.
- 一个特定的受体域,模仿 hirudin 的 carboxyl 尾巴,被确定为通过其阴离子结合的 exosite 对血栓蛋白的强效结合至关重要.
结论:
- 受体蛋白解是激素受体激活的唯一决定因素.
- 建立了血栓蛋白与受体相互作用的模型,突出了与希鲁丁类似的域.
- 这种模型有助于设计用于血栓形成治疗的新型血栓激素抑制剂.
相关概念视频
The Blood-brain Barrier
Overview
Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
Blood Transfusion
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...


